ORISE GEL
Received Nov 30, 2022 · Event occurred Nov 1, 2022
Report 3005099803-2022-06994 · MDR key 15889947
Device
Generic name
Submucosal Injection Agent
Manufacturer
Boston Scientific CorporationProduct problems
- Adverse Event Without Identified Device or Use Problem
- Adverse Event Without Identified Device or Use Problem
Patient
Unknown
- Granuloma
- Granuloma
Narrative
Additional Manufacturer Narrative
THE EXACT DATE OF THE EVENT IS UNKNOWN. THE PROVIDED EVENT DATE WAS CHOSEN AS A BEST ESTIMATE BASED ON THE DATE THAT THE MANUFACTURER BECAME AWARE OF THE EVENT. THE COMPLAINANT WAS UNABLE TO PROVIDE THE SUSPECT DEVICE LOT NUMBER; THEREFORE, THE LOT EXPIRATION AND DEVICE MANUFACTURE DATES ARE UNKNOWN. (B)(4).
Description of Event or Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT AN ORISE GEL WAS USED DURING A PROCEDURE PERFORMED ON AN UNKNOWN DATE. AFTER THE COMPLETION OF ENDOSCOPIC MUCOSAL RESECTION (EMR) AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) PROCEDURES, THE PHYSICIAN IS VERY CONCERNED ABOUT RESIDUAL ORISE GEL BEING LEFT BEHIND AS IT CAN CAUSE CONFUSION WITH MALIGNANCY. REPORTEDLY, THEY HAVE OBSERVED SUBMUCOSAL DISTORTIONS OR MASS FORMATIONS FOLLOWING THE USE OF ORISE GEL. THESE DISTORTIONS/ MASS FORMATIONS HAVE BEEN ASSESSED BY PERFORMING BIOPSIES. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION REGARDING THE CIRCUMSTANCES SURROUNDING THIS EVENT HAVE BEEN UNSUCCESSFUL TO DATE. SHOULD ADDITIONAL RELEVANT DETAILS BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
Remedial action
- Notification